These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 39107686

  • 1. Clinical manifestations and immune markers of non-HIV-related CMV retinitis.
    Passarin O, Hoogewoud F, Manuel O, Guex-Crosier Y.
    BMC Infect Dis; 2024 Aug 06; 24(1):787. PubMed ID: 39107686
    [Abstract] [Full Text] [Related]

  • 2. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D.
    J Infect Dis; 2005 Mar 15; 191(6):873-80. PubMed ID: 15717261
    [Abstract] [Full Text] [Related]

  • 3. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000 Mar 15; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 4. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
    Wohl DA, Kendall MA, Owens S, Holland G, Nokta M, Spector SA, Schrier R, Fiscus S, Davis M, Jacobson MA, Currier JS, Squires K, Alston-Smith B, Andersen J, Freeman WR, Higgins M, Torriani FJ, ACTG 379 Study Team.
    HIV Clin Trials; 2005 Mar 15; 6(3):136-46. PubMed ID: 16192248
    [Abstract] [Full Text] [Related]

  • 5. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
    Arevalo JF, Mendoza AJ, Ferretti Y.
    Retina; 2003 Aug 15; 23(4):495-502. PubMed ID: 12972761
    [Abstract] [Full Text] [Related]

  • 6. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR.
    Ophthalmology; 2000 May 15; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [Abstract] [Full Text] [Related]

  • 7. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.
    JAMA; 1999 Nov 03; 282(17):1633-7. PubMed ID: 10553789
    [Abstract] [Full Text] [Related]

  • 8. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus.
    Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R.
    J Acquir Immune Defic Syndr (1988); 1992 Nov 03; 5(11):1069-74. PubMed ID: 1357151
    [Abstract] [Full Text] [Related]

  • 9. Clinical profile and immunological status of cytomegalovirus retinitis in organ transplant recipients.
    Wagle AM, Biswas J, Gopal L, Madhavan HN.
    Indian J Ophthalmol; 2002 Jun 03; 50(2):115-21. PubMed ID: 12194567
    [Abstract] [Full Text] [Related]

  • 10. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF, Garcia RA, Mendoza AJ.
    Eur J Ophthalmol; 2005 Jun 03; 15(5):610-8. PubMed ID: 16167292
    [Abstract] [Full Text] [Related]

  • 11. Visual field loss in patients with cytomegalovirus retinitis.
    Thorne JE, Van Natta ML, Jabs DA, Duncan JL, Srivastava SK, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2011 May 03; 118(5):895-901. PubMed ID: 21146225
    [Abstract] [Full Text] [Related]

  • 12. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
    Karavellas MP, Azen SP, MacDonald JC, Shufelt CL, Lowder CY, Plummer DJ, Glasgow B, Torriani FJ, Freeman WR.
    Retina; 2001 May 03; 21(1):1-9. PubMed ID: 11217922
    [Abstract] [Full Text] [Related]

  • 13. Correlation between intraocular pressure and CD4+ T-lymphocyte counts in patients with human immunodeficiency virus with and without cytomegalovirus retinitis.
    Arevalo JF, Munguia D, Faber D, Friedlander SM, Quiceno JI, Rahhal FM, Kirsch LS, Freeman WR.
    Am J Ophthalmol; 1996 Jul 03; 122(1):91-6. PubMed ID: 8659603
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.
    Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA, Studies of Ocular Complications of AIDS (SOCA) Research Group.
    Am J Ophthalmol; 2011 Oct 03; 152(4):628-637.e1. PubMed ID: 21742304
    [Abstract] [Full Text] [Related]

  • 16. A cross-sectional study of cytomegalovirus retinitis in HIV-1 infected adults in Nigeria.
    Adeiza MA, Habib AG.
    Niger J Clin Pract; 2019 Mar 03; 22(3):293-297. PubMed ID: 30837414
    [Abstract] [Full Text] [Related]

  • 17. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy.
    Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR, Schrier RD.
    AIDS; 2000 Jan 28; 14(2):173-80. PubMed ID: 10708288
    [Abstract] [Full Text] [Related]

  • 18. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM.
    J Infect Dis; 2001 Apr 15; 183(8):1285-9. PubMed ID: 11262214
    [Abstract] [Full Text] [Related]

  • 19. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.
    Cassoux N, Lumbroso L, Bodaghi B, Zazoun L, Katlama C, LeHoang P.
    Br J Ophthalmol; 1999 Jan 15; 83(1):47-9. PubMed ID: 10209434
    [Abstract] [Full Text] [Related]

  • 20. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
    Reed JB, Briggs JW, McDonald JC, Freeman WR, Morse LS.
    Retina; 2001 Jan 15; 21(4):339-43. PubMed ID: 11508879
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.